In a 2-year study, we examined bone mass and calcium metabolism in 36 elderly women with moderate osteoporosis. The study period comprised 1 year of observation, during which the women received no treatment affecting calcium metabolism, and 1 year of treatment, during which all participants received
β¦ LIBER β¦
Growth hormone with and without salmon calcitonin in the treatment of postmenopausal osteoporosis
β Scribed by S. Gonnelli; C. Cepollaro; A. Montagnani; M S. Campagna; M B. Franci; C. Gennari
- Publisher
- Springer-Verlag
- Year
- 1996
- Tongue
- English
- Weight
- 120 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Rectal salmon calcitonin for the treatme
β
Kirsten Overgaard; Marc Allan Hansen; Karen-Lisbeth Dirksen; Claus Christiansen
π
Article
π
1992
π
Springer
π
English
β 530 KB
Treatment of postmenopausal osteoporosis
β
S. Adami; M. C. Baroni; M. Broggini; L. Carratelli; I. Caruso; L. Gnessi; M. Lau
π
Article
π
1993
π
Springer-Verlag
π
English
β 910 KB
Salmon calcitonin (Miacalcic) nasal spra
β
C. Gennari
π
Article
π
1989
π
Springer
π
English
β 395 KB
Total and regional bone mineral content
β
H. Rico; M. Revilla; E. R. HernΓ‘ndez; L. F. Villa; M. Alvarez Buergo
π
Article
π
1995
π
Springer
π
English
β 573 KB
Seventy-two postmenopausal osteoporotic women having more than one nontraumatic vertebral crush fracture were studied. Thirty-six of them, aged 68.8 +/- 1.2 years (18 +/- 4 YSM-years since menopause), were treated with 100 IU/day of salmon calcitonin i.m. plus 500 mg of elemental calcium for 10 days
Calcitonin in the prevention and treatme
β
C. H. Chestnut
π
Article
π
1993
π
Springer-Verlag
π
English
β 161 KB
Lack of hormonal changes in postmenopaus
β
H. Rico; A. Charro; I. Depablos; E. Bordiu; E. R. Hernandez; D. Espinos
π
Article
π
1984
π
Springer
π
English
β 460 KB